Funder: Food and Drug Administration
Due Dates: Forecasted (no due date posted)
Funding Amounts: $250,000 (single award; cooperative agreement)
Summary: Supports research to develop non-invasive imaging technologies for measuring topical drug penetration in skin, aiming to enable new methods for demonstrating bioequivalence of topical products.
Key Information: This is a forecasted opportunity; application details and deadlines are not yet posted.
Description
This funding opportunity from the Food and Drug Administration (FDA) aims to support research and development of non-invasive, tomography-based technologies to evaluate the pharmacokinetics of topically applied drug products in the skin. The goal is to develop accurate, sensitive, and reproducible methods and apparatus that can rapidly measure the amount of drug present at various depths within the skin in vivo, enabling serial monitoring over time. The ultimate intent is to create a scientifically valid, in vivo cutaneous pharmacokinetic approach that can efficiently demonstrate the bioequivalence of topical drug products, providing an alternative to current methods.
Due Dates
- This is a forecasted opportunity; no application due date has been posted yet.
- Researchers should monitor the official grant page for updates.
Funding Amount
- Award Ceiling: $250,000
- Award Floor: $250,000
- Number of Awards: 1
- Funding Mechanism: Cooperative Agreement
Eligibility
Eligible applicants include:
- State, county, city, or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (federally recognized and other tribal organizations)
- Public housing authorities/Indian housing authorities
- Nonprofits (with or without 501(c)(3) status, other than institutions of higher education)
- Private institutions of higher education
- For-profit organizations (including small businesses)
- Others, as specified in the opportunity
- Unrestricted: Open to any type of entity above, subject to clarification in the official notice
Additional notes:
- Organizations may submit more than one application if each is scientifically distinct.
- Duplicate or highly overlapping applications will not be accepted for review at the same time.
Application Process
- As this is a forecasted opportunity, application instructions and deadlines are not yet available.
- Interested applicants should regularly check the Grants.gov listing for updates and the official application package once posted.
- Prepare to demonstrate scientific distinctness if submitting multiple applications.
Additional Information
- No cost sharing or matching is required.
- The opportunity requires a clinical trial (U01 mechanism).
- The project is intended to advance regulatory science and support FDA’s mission to improve drug evaluation methodologies.
External Links
Contact Information